BridgeBio Oncology Therapeutics, Inc. (BBOT)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 8, 2025 | CORRESP | Neutral/Informational | Moderate | Helix Acquisition Corp. II has submitted a correspondence to the SEC regarding the acceleration of the effective date for its Registration Statement on Form S-1. The company is re… | Read Filing EDGAR |
| Sep. 3, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 3, 2025, informs Eli Wallace, CEO of BridgeBio Oncology Therapeutics, Inc., that the SEC has not reviewed and will not review their registra… | Read Filing EDGAR |
| Jul. 9, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence is a formal request from Helix Acquisition Corp. II and TheRas, Inc. to the SEC for the acceleration of their Registration Statement on Form S-4. They are seeki… | Read Filing EDGAR |
| Jul. 1, 2025 | CORRESP | Neutral/Informational | Low | The correspondence from BridgeBio Oncology Therapeutics, Inc. and Helix Acquisition Corp. II addresses comments from the SEC regarding their Registration Statement on Form S-4. Th… | Read Filing EDGAR |
| Jun. 27, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the registration statement filed by Helix Acquisition Corp. II and TheRas, Inc. and provided comments that require a response. Key issues include the NTBV cal… | Read Filing EDGAR |
| Jun. 20, 2025 | CORRESP | Neutral/Informational | Low | The correspondence from BridgeBio Oncology Therapeutics, Inc. and Helix Acquisition Corp. II addresses comments from the SEC regarding their Draft Registration Statement on Form S… | Read Filing EDGAR |
| Jun. 11, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed the amended draft registration statement for Helix Acquisition Corp. II and TheRas, Inc. and provided comments that require a response. The SEC requests clari… | Read Filing EDGAR |
| May. 13, 2025 | UPLOAD | Concern from SEC | High | The SEC has provided comments on the draft registration statement submitted by Helix Acquisition Corp. II and TheRas, Inc. regarding their proposed business combination with Bridg… | Read Filing EDGAR |